Do inhaled corticosteroids decrease the risk of cardiovascular outcomes in patients with chronic obstructive pulmonary disease?

被引：0
|
作者：
Mannino, David M. [1 ,2 ]
机构：
[1] COPD Fdn, Miami, FL 33134 USA
[2] Univ Kentucky, Coll Med, Lexington, KY 40506 USA
来源：
THORAX | 2024年 / 80卷 / 02期
关键词：
COPD epidemiology; COPD Exacerbations; COPD Pharmacology; FLUTICASONE FUROATE; EXACERBATION; VILANTEROL; EVENTS; COPD;
D O I：
10.1136/thorax-2024-222606
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prescription of inhaled corticosteroids in primary care for patients with chronic obstructive pulmonary disease
    Choudhury, A
    Griffiths, CJ
    Feder, GS
    Wedzicha, JA
    THORAX, 2001, 56 : 86 - 86
  • [32] Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease
    Bourbeau, J
    Rouleau, MY
    Boucher, S
    THORAX, 1998, 53 (06) : 477 - 482
  • [33] Inhaled corticosteroids in chronic obstructive pulmonary disease: How significant is the risk of pneumonia and should it impact use of inhaled corticosteroids?
    Cavallazzi R.
    Singh S.
    Current Infectious Disease Reports, 2011, 13 (3) : 296 - 301
  • [34] Inhaled corticosteroids and the risk of new-onset arterial hypertension in patients with chronic obstructive pulmonary disease
    Meteran, H.
    Sivapalan, P.
    Ekloef, J.
    Saeed, M., I
    Jordan, A.
    Jensen, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease A Nationwide Cohort Study
    Lee, Ming-Chia
    Lee, Chih-Hsin
    Chien, Shu-Chen
    Chang, Jer-Hwa
    She, Han-Lin
    Wang, Jann-Yuan
    Yu, Ming-Chih
    MEDICINE, 2015, 94 (42) : e1723
  • [36] Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
    Saeed, Mohamad Isam
    Eklof, Josefin
    Achir, Imane
    Sivapalan, Pradeesh
    Meteran, Howraman
    Lokke, Anders
    Biering-Sorensen, Tor
    Knop, Filip Krag
    Jensen, Jens-Ulrik Staehr
    DIABETES OBESITY & METABOLISM, 2020, 22 (08): : 1348 - 1356
  • [37] Inhaled corticosteroids, eosinophils and chronic obstructive pulmonary disease exacerbations
    Golpe, Rafael
    Martin-Robles, Irene
    Sanjuan-Lopez, Pilar
    ARCHIVOS DE BRONCONEUMOLOGIA, 2016, 52 (10): : 540 - 540
  • [38] Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease
    Bonay, M
    Bancal, C
    Crestani, B
    DRUG SAFETY, 2002, 25 (01) : 57 - 71
  • [39] Inhaled corticosteroids for stable chronic obstructive pulmonary disease (Review)
    Yang, I. A.
    Fong, K. M.
    Sim, E. H. A.
    Black, P. N.
    Lasserson, T. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [40] Inhaled corticosteroids in chronic obstructive pulmonary disease - Is there a clinical benefit?
    Man, SFP
    Sin, DD
    DRUGS, 2005, 65 (05) : 579 - 591
12345